English
简体中文
Total: £ 56.28
Published Date: 2026-01-08 | Pages: 112 | Tables: 118 | Medical Devices & Consumables
The global Peptide Synthesis CMO market was valued at US$ 3513 million in 2025 and is anticipated to reach US$ 8215 million by 2032, at a CAGR of 12.7% from 2026 to 2032.
Peptides, as unique drug compounds, lie between small molecules and proteins, but differ in biochemistry and therapy. They offer opportunities for therapeutic interventions that closely mimic natural pathways and play a major role in various physiological processes in the human body, including hormones and neurotransmitters, or in inflammatory responses. Peptides can be extracted naturally or synthesized artificially, and their high purity and controllable quality have made them popular drugs. Small molecule drugs rarely possess the high selectivity and rapid onset of action of peptides.
A Peptide Synthesis CMO (Contract Manufacturing Organization) is a specialized third-party manufacturer that provides custom and large-scale peptide production services for pharmaceutical, biotechnology, and research companies under contract. These organizations offer end-to-end or modular services covering peptide design support, solid-phase and liquid-phase synthesis, peptide–drug conjugate and modified peptide production, purification (e.g., preparative HPLC), lyophilization, analytical characterization, and GMP or non-GMP manufacturing according to the client’s development stage. Peptide Synthesis CMOs operate under stringent quality systems and regulatory standards, help sponsors reduce capital investment in internal manufacturing facilities, accelerate development timelines, and flexibly scale from milligram research batches to multi-kilogram commercial supply for APIs and peptide-based drug products.
The growth of the Peptide Synthesis CMO market is primarily driven by the rapid expansion of peptide therapeutics and the structural shift toward outsourcing. An increasing number of peptide drugs are being developed for metabolic disease, oncology, infectious disease and rare disorders, with more candidates entering clinical stages and requiring GMP-grade APIs and finished dosage forms. Sponsors prefer asset-light models and rely on specialized CMOs to provide end-to-end services—from route scouting and process development to large-scale manufacturing and aseptic fill–finish—so they can focus internal resources on discovery and clinical strategy. At the same time, the rising complexity of peptide molecules (long chains, cyclic and stapled structures, PEGylation, lipidation and conjugates) makes specialized equipment, advanced purification and sophisticated analytical methods indispensable, further reinforcing the role of highly capable CMOs. Integration of API and FDF capabilities, digitalization, automation, and green chemistry initiatives also act as important growth catalysts, enhancing efficiency, lowering cost of goods and aligning with big pharma’s ESG and supply chain resilience requirements.
However, the market also faces significant challenges and restraints that can slow expansion and compress margins. Peptide manufacturing is intrinsically high-cost due to expensive protected amino acids, resins and solvents, and complex purification, while large pharma and well-capitalized biotechs exert strong price pressure and often dominate contract terms. Technical risk is substantial: difficult sequences and complex modifications can lead to low yields, high scrap rates and project delays, especially for CMOs without deep scientific and analytical expertise. On top of this, increasingly stringent global regulations on impurities, nitrosamines, data integrity and GMP compliance raise the bar for quality systems and require continuous investment in equipment, IT and talent. Many players also struggle with capacity bottlenecks, dependence on a few major customers, and vulnerability to disruptions in key raw material supply. Together, these factors create a market where demand is structurally growing, but only CMOs that can manage cost, scale, regulatory complexity and technical risk simultaneously are likely to translate that demand into sustainable, profitable growth.
This report delivers a comprehensive overview of the global Peptide Synthesis CMO market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Peptide Synthesis CMO. The Peptide Synthesis CMO market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Peptide Synthesis CMO market comprehensively. Regional market sizes by Type, by Application, by Project Stage, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Peptide Synthesis CMO manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Medtide
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific
Segment by Type
APIs and Intermediates
FDF
Segment by Project Stage
Clinical GMP
Non-GMP
Commercial GMP
Segment by Customer Type
Large Pharma
Biotech Pharma
Academic
Segment by Application
Commercial
Academic Research
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Project Stage, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Peptide Synthesis CMO companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Synthesis CMO Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 APIs and Intermediates
1.2.3 FDF
1.3 Market by Project Stage
1.3.1 Global Peptide Synthesis CMO Market Size Growth Rate by Project Stage: 2021 vs 2025 vs 2032
1.3.2 Clinical GMP
1.3.3 Non-GMP
1.3.4 Commercial GMP
1.4 Market by Customer Type
1.4.1 Global Peptide Synthesis CMO Market Size Growth Rate by Customer Type: 2021 vs 2025 vs 2032
1.4.2 Large Pharma
1.4.3 Biotech Pharma
1.4.4 Academic
1.5 Market by Application
1.5.1 Global Peptide Synthesis CMO Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Commercial
1.5.3 Academic Research
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Peptide Synthesis CMO Market Perspective (2021–2032)
2.2 Global Peptide Synthesis CMO Growth Trends by Region
2.2.1 Global Peptide Synthesis CMO Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Peptide Synthesis CMO Historic Market Size by Region (2021–2026)
2.2.3 Peptide Synthesis CMO Forecasted Market Size by Region (2027–2032)
2.3 Peptide Synthesis CMO Market Dynamics
2.3.1 Peptide Synthesis CMO Industry Trends
2.3.2 Peptide Synthesis CMO Market Drivers
2.3.3 Peptide Synthesis CMO Market Challenges
2.3.4 Peptide Synthesis CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Synthesis CMO Players by Revenue
3.1.1 Global Top Peptide Synthesis CMO Players by Revenue (2021–2026)
3.1.2 Global Peptide Synthesis CMO Revenue Market Share by Players (2021–2026)
3.2 Global Top Peptide Synthesis CMO Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Peptide Synthesis CMO Revenue
3.4 Global Peptide Synthesis CMO Market Concentration Ratio
3.4.1 Global Peptide Synthesis CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Synthesis CMO Revenue in 2025
3.5 Global Key Players of Peptide Synthesis CMO Head Offices and Areas Served
3.6 Global Key Players of Peptide Synthesis CMO, Products and Applications
3.7 Global Key Players of Peptide Synthesis CMO, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Peptide Synthesis CMO Breakdown Data by Type
4.1 Global Peptide Synthesis CMO Historic Market Size by Type (2021–2026)
4.2 Global Peptide Synthesis CMO Forecasted Market Size by Type (2027–2032)
5 Peptide Synthesis CMO Breakdown Data by Application
5.1 Global Peptide Synthesis CMO Historic Market Size by Application (2021–2026)
5.2 Global Peptide Synthesis CMO Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Peptide Synthesis CMO Market Size (2021–2032)
6.2 North America Peptide Synthesis CMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Peptide Synthesis CMO Market Size by Country (2021–2026)
6.4 North America Peptide Synthesis CMO Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Synthesis CMO Market Size (2021–2032)
7.2 Europe Peptide Synthesis CMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Peptide Synthesis CMO Market Size by Country (2021–2026)
7.4 Europe Peptide Synthesis CMO Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Peptide Synthesis CMO Market Size (2021–2032)
8.2 Asia-Pacific Peptide Synthesis CMO Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Peptide Synthesis CMO Market Size by Region (2021–2026)
8.4 Asia-Pacific Peptide Synthesis CMO Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Peptide Synthesis CMO Market Size (2021–2032)
9.2 Latin America Peptide Synthesis CMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Peptide Synthesis CMO Market Size by Country (2021–2026)
9.4 Latin America Peptide Synthesis CMO Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Synthesis CMO Market Size (2021–2032)
10.2 Middle East & Africa Peptide Synthesis CMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Peptide Synthesis CMO Market Size by Country (2021–2026)
10.4 Middle East & Africa Peptide Synthesis CMO Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Synthesis CMO Introduction
11.1.4 Bachem Revenue in Peptide Synthesis CMO Business (2021–2026)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide Synthesis CMO Introduction
11.2.4 PolyPeptide Revenue in Peptide Synthesis CMO Business (2021–2026)
11.2.5 PolyPeptide Recent Development
11.3 USV Peptides
11.3.1 USV Peptides Company Details
11.3.2 USV Peptides Business Overview
11.3.3 USV Peptides Peptide Synthesis CMO Introduction
11.3.4 USV Peptides Revenue in Peptide Synthesis CMO Business (2021–2026)
11.3.5 USV Peptides Recent Development
11.4 Thermofischer
11.4.1 Thermofischer Company Details
11.4.2 Thermofischer Business Overview
11.4.3 Thermofischer Peptide Synthesis CMO Introduction
11.4.4 Thermofischer Revenue in Peptide Synthesis CMO Business (2021–2026)
11.4.5 Thermofischer Recent Development
11.5 Bio Basic
11.5.1 Bio Basic Company Details
11.5.2 Bio Basic Business Overview
11.5.3 Bio Basic Peptide Synthesis CMO Introduction
11.5.4 Bio Basic Revenue in Peptide Synthesis CMO Business (2021–2026)
11.5.5 Bio Basic Recent Development
11.6 JPT
11.6.1 JPT Company Details
11.6.2 JPT Business Overview
11.6.3 JPT Peptide Synthesis CMO Introduction
11.6.4 JPT Revenue in Peptide Synthesis CMO Business (2021–2026)
11.6.5 JPT Recent Development
11.7 Genscript
11.7.1 Genscript Company Details
11.7.2 Genscript Business Overview
11.7.3 Genscript Peptide Synthesis CMO Introduction
11.7.4 Genscript Revenue in Peptide Synthesis CMO Business (2021–2026)
11.7.5 Genscript Recent Development
11.8 Medtide
11.8.1 Medtide Company Details
11.8.2 Medtide Business Overview
11.8.3 Medtide Peptide Synthesis CMO Introduction
11.8.4 Medtide Revenue in Peptide Synthesis CMO Business (2021–2026)
11.8.5 Medtide Recent Development
11.9 ScinoPharm
11.9.1 ScinoPharm Company Details
11.9.2 ScinoPharm Business Overview
11.9.3 ScinoPharm Peptide Synthesis CMO Introduction
11.9.4 ScinoPharm Revenue in Peptide Synthesis CMO Business (2021–2026)
11.9.5 ScinoPharm Recent Development
11.10 AmbioPharm
11.10.1 AmbioPharm Company Details
11.10.2 AmbioPharm Business Overview
11.10.3 AmbioPharm Peptide Synthesis CMO Introduction
11.10.4 AmbioPharm Revenue in Peptide Synthesis CMO Business (2021–2026)
11.10.5 AmbioPharm Recent Development
11.11 SN Biopharm
11.11.1 SN Biopharm Company Details
11.11.2 SN Biopharm Business Overview
11.11.3 SN Biopharm Peptide Synthesis CMO Introduction
11.11.4 SN Biopharm Revenue in Peptide Synthesis CMO Business (2021–2026)
11.11.5 SN Biopharm Recent Development
11.12 CBL
11.12.1 CBL Company Details
11.12.2 CBL Business Overview
11.12.3 CBL Peptide Synthesis CMO Introduction
11.12.4 CBL Revenue in Peptide Synthesis CMO Business (2021–2026)
11.12.5 CBL Recent Development
11.13 Piramal Pharma
11.13.1 Piramal Pharma Company Details
11.13.2 Piramal Pharma Business Overview
11.13.3 Piramal Pharma Peptide Synthesis CMO Introduction
11.13.4 Piramal Pharma Revenue in Peptide Synthesis CMO Business (2021–2026)
11.13.5 Piramal Pharma Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Company Details
11.14.2 CordenPharma Business Overview
11.14.3 CordenPharma Peptide Synthesis CMO Introduction
11.14.4 CordenPharma Revenue in Peptide Synthesis CMO Business (2021–2026)
11.14.5 CordenPharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Details
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific Peptide Synthesis CMO Introduction
11.15.4 CPC Scientific Revenue in Peptide Synthesis CMO Business (2021–2026)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide Synthesis CMO Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of APIs and Intermediates
Table 3. Key Players of FDF
Table 4. Global Peptide Synthesis CMO Market Size Growth Rate by Project Stage (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Clinical GMP
Table 6. Key Players of Non-GMP
Table 7. Key Players of Commercial GMP
Table 8. Global Peptide Synthesis CMO Market Size Growth Rate by Customer Type (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of Large Pharma
Table 10. Key Players of Biotech Pharma
Table 11. Key Players of Academic
Table 12. Global Peptide Synthesis CMO Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Peptide Synthesis CMO Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Peptide Synthesis CMO Market Size by Region (US$ Million), 2021–2026
Table 15. Global Peptide Synthesis CMO Market Share by Region (2021–2026)
Table 16. Global Peptide Synthesis CMO Forecasted Market Size by Region (US$ Million), 2027–2032
Table 17. Global Peptide Synthesis CMO Market Share by Region (2027–2032)
Table 18. Peptide Synthesis CMO Market Trends
Table 19. Peptide Synthesis CMO Market Drivers
Table 20. Peptide Synthesis CMO Market Challenges
Table 21. Peptide Synthesis CMO Market Restraints
Table 22. Global Peptide Synthesis CMO Revenue by Players (US$ Million), 2021–2026
Table 23. Global Peptide Synthesis CMO Market Share by Players (2021–2026)
Table 24. Global Top Peptide Synthesis CMO Players by Tier (Tier 1, Tier 2, and Tier 3), based on Peptide Synthesis CMO Revenue, 2025
Table 25. Ranking of Global Top Peptide Synthesis CMO Companies by Revenue (US$ Million) in 2025
Table 26. Global 5 Largest Players Market Share by Peptide Synthesis CMO Revenue (CR5 and HHI), 2021–2026
Table 27. Global Key Players of Peptide Synthesis CMO, Headquarters and Area Served
Table 28. Global Key Players of Peptide Synthesis CMO, Products and Applications
Table 29. Global Key Players of Peptide Synthesis CMO, Date of General Availability (GA)
Table 30. Mergers and Acquisitions, Expansion Plans
Table 31. Global Peptide Synthesis CMO Market Size by Type (US$ Million), 2021–2026
Table 32. Global Peptide Synthesis CMO Revenue Market Share by Type (2021–2026)
Table 33. Global Peptide Synthesis CMO Forecasted Market Size by Type (US$ Million), 2027–2032
Table 34. Global Peptide Synthesis CMO Revenue Market Share by Type (2027–2032)
Table 35. Global Peptide Synthesis CMO Market Size by Application (US$ Million), 2021–2026
Table 36. Global Peptide Synthesis CMO Revenue Market Share by Application (2021–2026)
Table 37. Global Peptide Synthesis CMO Forecasted Market Size by Application (US$ Million), 2027–2032
Table 38. Global Peptide Synthesis CMO Revenue Market Share by Application (2027–2032)
Table 39. North America Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. North America Peptide Synthesis CMO Market Size by Country (US$ Million), 2021–2026
Table 41. North America Peptide Synthesis CMO Market Size by Country (US$ Million), 2027–2032
Table 42. Europe Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Europe Peptide Synthesis CMO Market Size by Country (US$ Million), 2021–2026
Table 44. Europe Peptide Synthesis CMO Market Size by Country (US$ Million), 2027–2032
Table 45. Asia-Pacific Peptide Synthesis CMO Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 46. Asia-Pacific Peptide Synthesis CMO Market Size by Region (US$ Million), 2021–2026
Table 47. Asia-Pacific Peptide Synthesis CMO Market Size by Region (US$ Million), 2027–2032
Table 48. Latin America Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Latin America Peptide Synthesis CMO Market Size by Country (US$ Million), 2021–2026
Table 50. Latin America Peptide Synthesis CMO Market Size by Country (US$ Million), 2027–2032
Table 51. Middle East & Africa Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Middle East & Africa Peptide Synthesis CMO Market Size by Country (US$ Million), 2021–2026
Table 53. Middle East & Africa Peptide Synthesis CMO Market Size by Country (US$ Million), 2027–2032
Table 54. Bachem Company Details
Table 55. Bachem Business Overview
Table 56. Bachem Peptide Synthesis CMO Product
Table 57. Bachem Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 58. Bachem Recent Development
Table 59. PolyPeptide Company Details
Table 60. PolyPeptide Business Overview
Table 61. PolyPeptide Peptide Synthesis CMO Product
Table 62. PolyPeptide Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 63. PolyPeptide Recent Development
Table 64. USV Peptides Company Details
Table 65. USV Peptides Business Overview
Table 66. USV Peptides Peptide Synthesis CMO Product
Table 67. USV Peptides Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 68. USV Peptides Recent Development
Table 69. Thermofischer Company Details
Table 70. Thermofischer Business Overview
Table 71. Thermofischer Peptide Synthesis CMO Product
Table 72. Thermofischer Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 73. Thermofischer Recent Development
Table 74. Bio Basic Company Details
Table 75. Bio Basic Business Overview
Table 76. Bio Basic Peptide Synthesis CMO Product
Table 77. Bio Basic Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 78. Bio Basic Recent Development
Table 79. JPT Company Details
Table 80. JPT Business Overview
Table 81. JPT Peptide Synthesis CMO Product
Table 82. JPT Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 83. JPT Recent Development
Table 84. Genscript Company Details
Table 85. Genscript Business Overview
Table 86. Genscript Peptide Synthesis CMO Product
Table 87. Genscript Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 88. Genscript Recent Development
Table 89. Medtide Company Details
Table 90. Medtide Business Overview
Table 91. Medtide Peptide Synthesis CMO Product
Table 92. Medtide Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 93. Medtide Recent Development
Table 94. ScinoPharm Company Details
Table 95. ScinoPharm Business Overview
Table 96. ScinoPharm Peptide Synthesis CMO Product
Table 97. ScinoPharm Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 98. ScinoPharm Recent Development
Table 99. AmbioPharm Company Details
Table 100. AmbioPharm Business Overview
Table 101. AmbioPharm Peptide Synthesis CMO Product
Table 102. AmbioPharm Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 103. AmbioPharm Recent Development
Table 104. SN Biopharm Company Details
Table 105. SN Biopharm Business Overview
Table 106. SN Biopharm Peptide Synthesis CMO Product
Table 107. SN Biopharm Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 108. SN Biopharm Recent Development
Table 109. CBL Company Details
Table 110. CBL Business Overview
Table 111. CBL Peptide Synthesis CMO Product
Table 112. CBL Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 113. CBL Recent Development
Table 114. Piramal Pharma Company Details
Table 115. Piramal Pharma Business Overview
Table 116. Piramal Pharma Peptide Synthesis CMO Product
Table 117. Piramal Pharma Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 118. Piramal Pharma Recent Development
Table 119. CordenPharma Company Details
Table 120. CordenPharma Business Overview
Table 121. CordenPharma Peptide Synthesis CMO Product
Table 122. CordenPharma Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 123. CordenPharma Recent Development
Table 124. CPC Scientific Company Details
Table 125. CPC Scientific Business Overview
Table 126. CPC Scientific Peptide Synthesis CMO Product
Table 127. CPC Scientific Revenue in Peptide Synthesis CMO Business (US$ Million), 2021–2026
Table 128. CPC Scientific Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 132. Authors List of This Report
List of Figures
Figure 1. Peptide Synthesis CMO Picture
Figure 2. Global Peptide Synthesis CMO Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Peptide Synthesis CMO Market Share by Type: 2025 vs 2032
Figure 4. APIs and Intermediates Features
Figure 5. FDF Features
Figure 6. Global Peptide Synthesis CMO Market Size Comparison by Project Stage (US$ Million), 2021–2032
Figure 7. Clinical GMP Features
Figure 8. Non-GMP Features
Figure 9. Commercial GMP Features
Figure 10. Global Peptide Synthesis CMO Market Size Comparison by Customer Type (US$ Million), 2021–2032
Figure 11. Large Pharma Features
Figure 12. Biotech Pharma Features
Figure 13. Academic Features
Figure 14. Global Peptide Synthesis CMO Market Size by Application (US$ Million), 2021–2032
Figure 15. Global Peptide Synthesis CMO Market Share by Application: 2025 vs 2032
Figure 16. Commercial Case Studies
Figure 17. Academic Research Case Studies
Figure 18. Other Case Studies
Figure 19. Peptide Synthesis CMO Report Years Considered
Figure 20. Global Peptide Synthesis CMO Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 21. Global Peptide Synthesis CMO Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Peptide Synthesis CMO Market Share by Region: 2025 vs 2032
Figure 23. Global Peptide Synthesis CMO Market Share by Players in 2025
Figure 24. Global Peptide Synthesis CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. The Top 10 and 5 Players Market Share by Peptide Synthesis CMO Revenue in 2025
Figure 26. North America Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. North America Peptide Synthesis CMO Market Share by Country (2021–2032)
Figure 28. United States Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Canada Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Europe Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Peptide Synthesis CMO Market Share by Country (2021–2032)
Figure 32. Germany Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. France Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. U.K. Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Italy Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Russia Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Ireland Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Asia-Pacific Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Peptide Synthesis CMO Market Share by Region (2021–2032)
Figure 40. China Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Japan Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. South Korea Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Southeast Asia Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. India Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Australia & New Zealand Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Latin America Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Peptide Synthesis CMO Market Share by Country (2021–2032)
Figure 48. Mexico Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Brazil Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Middle East & Africa Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Peptide Synthesis CMO Market Share by Country (2021–2032)
Figure 52. Israel Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Saudi Arabia Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. UAE Peptide Synthesis CMO Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Bachem Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 56. PolyPeptide Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 57. USV Peptides Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 58. Thermofischer Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 59. Bio Basic Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 60. JPT Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 61. Genscript Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 62. Medtide Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 63. ScinoPharm Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 64. AmbioPharm Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 65. SN Biopharm Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 66. CBL Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 67. Piramal Pharma Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 68. CordenPharma Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 69. CPC Scientific Revenue Growth Rate in Peptide Synthesis CMO Business (2021–2026)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
